Results of the VANISH-2 trial, building on prior research, further upheld superiority of catheter ablation over ...

Presentations at Heart Rhythm 2025 for Field Medical Inc. and Adagio Medical Holdings Inc. demonstrated success in two very ...

Though women have a lower risk of ventricular arrhythmias than do men, it still exceeds the threshold to justify a device.

The US guidelines are likely to change following the release of the VANISH2 results last year, Christine Albert anticipates.

Led by Farapulse founder Steven Mickelsen, Field has developed a pulsed field ablation device to tackle the dangerous heart ...

Often seen as an option of last resort for ventricular tachycardia, new research suggests catheter ablation could have a ...

Ventricular tachycardia is an abnormally fast ... N-terminal acetylation dysregulation in the heart causes severe arrhythmia and cardiomyopathy. The authors show that stem cell models demonstrate ...

FORT MILL, S.C., May 01, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the ...

Ventricular fibrillation after irregular tachycardia and prolonged ... Restoration of regular rhythm in mammalian fibrillating heart. Am. Rev. Soviet Med. 3:236, 1946. Guyton, A.

SELF-ADMINISTERED etripamil, an intranasal calcium channel blocker, significantly reduces emergency department (ED) visits ...